Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

0.3378
-0.0922-21.44%
Post-market: 0.3300-0.0078-2.31%19:59 EDT
Volume:6.95M
Turnover:2.57M
Market Cap:1.46M
PE:-0.03
High:0.4022
Open:0.4012
Low:0.3312
Close:0.4300
52wk High:24.30
52wk Low:0.3312
Shares:4.31M
Float Shares:4.04M
Volume Ratio:0.11
T/O Rate:172.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.05
PE(LYR):-0.02

Loading ...

Sunshine Biopharma Closes $6 Million Public Offering, Issues Series D Warrants for up to $14.4 Million Proceeds

Reuters
·
Yesterday

US Stocks on the MOVE-Palantir, Haemonetics

Reuters
·
Yesterday

Sunshine Biopharma Prices USD 6 Million Common Unit Public Offering

Reuters
·
Oct 08

US Stocks on the MOVE-Halozyme, Moderna, Merck

Reuters
·
Oct 08

NASDAQ Trade Halt Volatility Trading Pause at 10:33 Am

Reuters
·
Oct 07

Sunshine Biopharma Shareholder Consent Authorizes Reverse Stock Split of up to 1-for-20

Reuters
·
Sep 28

Sunshine Biopharma launches generic Zofran in Canada

TIPRANKS
·
Sep 24

Sunshine Biopharma Files Draft Information Statement on Potential Reverse Stock Split up to 1-for-20

Reuters
·
Sep 17

Sunshine Biopharma - Board Authorized to Effect Reverse Split of Common Stock up to 1-for-20 - SEC Filing

THOMSON REUTERS
·
Sep 17

Sunshine Biopharma Inc: Advances Lead Coronavirus Drug Candidate into Ind-Enabling Studies

THOMSON REUTERS
·
Sep 16

Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies

Reuters
·
Sep 16

Sunshine Biopharma Cuts Warrant Exercise Price to 1.2

Reuters
·
Sep 12

Health Canada: Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions

THOMSON REUTERS
·
Aug 31

Health Canada Approves Sunshine Biopharma Atenolol Tablets for Canada Market

Reuters
·
Aug 31

Sunshine Biopharma Director Andrew Keller Declines to Seek Board Reelection

Reuters
·
Aug 29

Sunshine Biopharma provides update, outlines plans for oncology project

TIPRANKS
·
Aug 26

Sunshine Biopharma Wins Canadian Approval for Generic Enalapril Tablets

Reuters
·
Aug 19

Sunshine Biopharma: Enalapril Expected to Begin Shipping to Canadian Pharmacies by Year-End 2026

THOMSON REUTERS
·
Aug 19

Sunshine Biopharma: Receives Canadian Regulatory Approval for Enalapril

THOMSON REUTERS
·
Aug 19

Sunshine Biopharma Q2 Net Loss Narrows 11.67% to $1.56 Million; Revenue Slips 1.6% to $9.26 Million

Reuters
·
Aug 14